HOME >> BIOLOGY >> NEWS
A New Look At Margerine And Health

Margarines are a healthy choice according to a CSIRO study.

The study, published recently in the American Journal of Clinical Nutrition, indicated that the benefits of polyunsaturated margarines are enhanced when they are also low in trans fatty acids, substances which raise total blood cholesterol.

Clinical trials conducted at CSIRO Human Nutrition in Adelaide, compared the effects of four types of margarine on blood cholesterol. The margarines were polyunsaturated or monounsaturated, with or without trans fatty acids. Thirty eight men and women with mildly elevated cholesterol took part in the feeding trial, lasting 11 weeks.

The results of the study showed that, compared to saturated fat spreads, any of the four margarines reduced the level of LDL (bad) cholesterol in the blood by 11 - 15 per cent. This corresponds to a fall in the risk of heart disease of approximately 20 - 30 per cent. HDL (good) cholesterol was unchanged. In an unexpected finding, the margarine high in polyunsaturates and low in trans fatty acids produced a greater fall in blood LDL-cholesterol than the other margarines.

"The margarine high in polyunsaturates and low in trans fatty acid lowered LDL-cholesterol a further 6 per cent compared to other margarines, a statistically significant difference", said CSIRO researcher Manny Noakes.

"Based on our data, the fall in heart disease risk could be reckoned to be 13 per cent greater with the polyunsaturated margarine without trans fatty acids than a similar spread with trans fatty acids."

Trans fatty acids are a minor class of fats found in small quantities in certain animal products. They used to be present in moderate quantities in margarines. However, there has been an international trend to reduce levels of trans fatty acids in margarines.

Approximately half the margarines on the Australian market do not contain trans fatty acids.

More information:
Manny Noakes, CSIRO, 08-83038827 or
Jenny Rhodes,
'"/>

Contact: Rosie Schmedding
rosie.schmedding@nap.csiro.au
61-2-6276-6520
CSIRO Australia
27-Nov-1998


Page: 1 2

Related biology news :

1. Health of worlds sea lions the focus of Wakefield Symposium
2. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
3. Institute for OneWorld Health nominated for the 2004 World Technology Awards
4. Healthy fats and oils essential to satisfy calorie-conscious consumers
5. Institute for OneWorld Health receives Gates Foundation grant
6. Donaghue Womens Health Investigator Program awards grants to three at Yale
7. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
8. Addressing the Healthcare Needs of Our Aging Population with Technology
9. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
10. OneWorld Health completes enrollment, treatment in Phase III India trial
11. Institute for OneWorld Health CEO advocates focus first on developing world markets

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Look Margerine And Health

(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
Cached News: